Skip to main content
. Author manuscript; available in PMC: 2020 Sep 16.
Published in final edited form as: J Health Commun. 2019 Sep 16;24(9):711–718. doi: 10.1080/10810730.2019.1665757

Table 1.

Demographic and clinical characteristics of the sample (N=56).

Patient Characteristic N %
Age (in years) M=67.95 SD=9.06
Gender
  Female 32 57.1%
  Male 24 42.9%
Marital status
  Married/partnered 34 60.7%
Race
  White 43 76.8%
  Black 7 12.5%
  Other 6 10.7%
Education
  Less than college degree 22 39.3%
  College degree or higher 34 60.7%
Type of Lung Cancer
  Non-small cell lung cancer (NSCLC) 30 53.6%
  Small cell lung cancer (SCLC) 13 23.2%
  Suspicious mass 13 23.2%
Pathological disease stage
  Stage IA 9 16.1%
  Stage IB 5 8.9%
  Stage IIA 1 1.8%
  Stage IIIA 5 8.9%
  Stage IIIB 3 5.4%
  Stage IV 13 23.2%
  Limited stage 7 12.5%
  Extensive stage 5 8.9%
  Suspicious mass, later non-malignant 5 8.9%
  Other 1 1.8%
  Stage unknown 2 3.6%
Smoking Status
  Current smoker 9 16.1%
  Former smoker 47 83.9%
Type of Lung Cancer Physician Seen
  Medical oncologist 21 37.5%
  Thoracic oncology surgeon 30 53.6%
  Radiation oncologist 5 8.9%